Delcath Systems Inc. (NASDAQ: DCTH) Stock Information | RedChip

Delcath Systems Inc. (NASDAQ: DCTH)


$11.2350
-0.2050 ( -1.45% ) 78.1K

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Market Data


Open


$11.2350

Previous close


$11.4400

Volume


78.1K

Market cap


$360.50M

Day range


$11.1500 - $11.6700

52 week range


$3.7000 - $13.3011

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Mar 19, 2024
8-k 8K-related 15 Mar 19, 2024
8-k 8K-related 18 Mar 19, 2024
4 Insider transactions 1 Mar 19, 2024
4 Insider transactions 1 Mar 19, 2024
4 Insider transactions 1 Mar 19, 2024
4 Insider transactions 1 Feb 20, 2024
4 Insider transactions 1 Feb 14, 2024
8-k 8K-related 14 Feb 14, 2024
4 Insider transactions 1 Feb 14, 2024

Latest News